p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer
Jinghui Liu(University of Kentucky), Xiaoqi Liu(University of Kentucky), Yifan Kong(University of Kentucky), Eun Y. Lee(University of Kentucky), Lijun Cheng(Taizhou Central Hospital), Karrie L. Jones(University of Kentucky), Xiongjian Rao(University of Kentucky), Daheng He(University of Kentucky), Chaohao Li(University of Kentucky), Jinpeng Liu(University of Kentucky), Zhuangzhuang Zhang(University of Kentucky), Changkun Huang(Central South University), Dana Napier(University of Kentucky), Chi Wang(University of Kentucky), Yanquan Zhang(University of Kentucky)
Cited by 114
Related Papers
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
|The American Journal of Human Genetics|2010|394
Transcriptome and epigenome landscape of human cortical development modeled in organoids
|Science|2018|314
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
|BMC Genomics|2016|228
Two gene co-expression modules differentiate psychotics and controls
|Molecular Psychiatry|2012|166